Author

M. Sczaniecka-Clift

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:genetic perturbation / CRISPR· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

P. Beli· 2 shared A. Barros· 1 shared A. Bradley· 1 shared A. R. Wanders· 1 shared A. Serrano-Benitez· 1 shared B. Fu· 1 shared C. J. Blum· 1 shared C. J. Carnie· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

P. Beli

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The dCMP deaminase DCTD and the E3 ligase TOPORS are central mediators of decitabine cytotoxicity

C. J. Carnie, M. J. Gotz, C. S. Palma-Chaundler, P. Weickert, A. R. Wanders, A. Serrano-Benitez, H.-Y. Li, V. Gupta, C. J. Blum, M. Sczaniecka-Clift, G. Zagnoli-Vieira, G. D'Alessandro, S. L. Richards, N. Gueorguieva, P. Beli, , S. P. Jackson

This study identifies DCTD and TOPORS as key factors in decitabine cytotoxicity by showing their roles in DPC formation and repair.

bioRxiv · Dec 21, 2023Cell Biology

ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks

G. Balmus, D. Pilger, J. Coates, M. Demir, M. Sczaniecka-Clift, A. Barros, M. Woods, B. Fu, F. Yang, E. Chen, M. Ostermaier, T. Stankovic, H. Ponstingl, M. Herzog, K. Yusa, , S. P. P. Jackson

The paper identifies how ATM counteracts toxic non-homologous end-joining at broken replication forks by showing that loss of NHEJ components or BRCA1-A complex confers resistance to DNA-damaging agents in ATM-deficient cells.

bioRxiv · May 24, 2018Cell Biology